Medications for Heart Defects Congenital

6 results

  • Edecrin (ethacrynic acid)

    (ethacrynic acid)
    Bausch Health US, LLC
    Usage: EDECRIN is indicated for treating edema related to congestive heart failure, cirrhosis, renal disease, and nephrotic syndrome. It also manages ascites, idiopathic edema, and lymphedema, particularly in hospitalized pediatric patients. Intravenous use is designated for rapid diuresis in acute situations or when oral administration is not an option.

  • Ethacrynic acid (ethacrynic acid)

    (Ethacrynic Acid)
    Bryant Ranch Prepack
    Usage: Ethacrynic Acid Tablets are indicated for treating edema when stronger diuretics are needed. They are used for edema related to congestive heart failure, liver cirrhosis, renal disease, as well as for managing ascites, idiopathic edema, lymphedema, and in hospitalized pediatric patients with congenital heart disease or nephrotic syndrome.

  • Ethacrynic acid (ethacrynic acid)

    (Ethacrynic Acid)
    ScieGen Pharmaceuticals Inc
    Usage: Ethacrynic Acid Tablets are indicated for treating edema when stronger diuretics are needed, including conditions like congestive heart failure, liver cirrhosis, renal disease, and short-term management of ascites, idiopathic edema, lymphedema, and in pediatric patients with congenital heart disease or nephrotic syndrome.

  • Ethacrynic acid (ethacrynic acid)

    (Ethacrynic Acid)
    Amneal Pharmaceuticals NY LLC
    Usage: Ethacrynic acid tablets are indicated for edema treatment requiring stronger diuretics, including conditions like congestive heart failure, cirrhosis, renal disease, ascites, and more. Intravenous formulation is used for rapid diuresis or when oral administration is not feasible, such as in acute pulmonary edema.

  • Ethacrynic sodium (ethacrynic sodium)

    (ethacrynic sodium)
    Oceanside Pharmaceuticals
    Usage: Ethacrynic acid is indicated for managing edema linked to congestive heart failure, liver cirrhosis, renal disease, malignancy-related ascites, idiopathic edema, lymphedema, and congenital heart disease in hospitalized pediatric patients. It can be administered intravenously for rapid diuresis in acute situations or when oral administration is not feasible.

  • Xarelto (rivaroxaban)

    (rivaroxaban)
    Cardinal Health 107, LLC
    Usage: XARELTO is indicated for reducing the risk of stroke and systemic embolism in nonvalvular atrial fibrillation, treating deep vein thrombosis (DVT) and pulmonary embolism (PE), preventing DVT post-surgery, and pediatric thromboprophylaxis. It also reduces major cardiovascular events in coronary artery disease and thrombotic events in peripheral artery disease patients.